Ricardo Nalda‐Molina
Ricardo Nalda‐Molina publishes mostly in Surgery, Pharmacology and Pediatrics, Perinatology and Child Health, on topics such as Antibiotics Pharmacokinetics and Efficacy, Renal Transplantation Outcomes and Treatments and Inflammatory Bowel Disease.
- World rank
- #5,589,262 of 7,710,434 ranked researchers
- Rank in Spain
- #132,361 of 204,306
- Works
- 38
- Citations
- 598
- Citations per work
- 15.7
What does Ricardo Nalda‐Molina research?
Ricardo Nalda‐Molina's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2156.2%
- Health Sciences1437.3%
- Medicine1437.3%
- Life Sciences26.5%
- 1Surgery9% of their works
- 2Pharmacology8% of their works
- 3Pediatrics, Perinatology and Child Health8% of their works
- 4Oncology6% of their works
- 5Genetics6% of their works
- 6Transplantation6% of their works
Research topics
- Antibiotics Pharmacokinetics and Efficacy
- Renal Transplantation Outcomes and Treatments
- Inflammatory Bowel Disease
- Biosimilars and Bioanalytical Methods
- Drug Transport and Resistance Mechanisms
- Intraperitoneal and Appendiceal Malignancies
- Nanoparticle-Based Drug Delivery
- Pharmacological Effects and Toxicity Studies
Which keywords describe Ricardo Nalda‐Molina's research?
The keywords of their largest research topics: Antibiotic Pharmacokinetics, Critically Ill Patients, Kidney Transplantation, Renal Allograft, ATP-dependent Transporters, Biosimilars, Crohn's Disease and Cytoreductive Surgery.
- Prenatal Exposure
- Drug Delivery
- Multidrug Resistance
- Inflammatory Bowel Disease
- Cytoreductive Surgery
- Biosimilars
- Renal Allograft
- Critically Ill Patients
- Antibiotic Pharmacokinetics
- Kidney Transplantation
- ATP-dependent Transporters
- Crohn's Disease
- Immunogenicity
- Intraperitoneal Chemotherapy
- Antiepileptic Drugs
- Nanocarriers
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Antibiotic Pharmacokinetics61 topic
- Critically Ill Patients61 topic
- Kidney Transplantation61 topic
- Renal Allograft61 topic
- ATP-dependent Transporters51 topic
- Biosimilars51 topic
- Crohn's Disease51 topic
- Cytoreductive Surgery51 topic
- Immunogenicity51 topic
- Inflammatory Bowel Disease51 topic
- Intraperitoneal Chemotherapy51 topic
- Multidrug Resistance51 topic
- Antiepileptic Drugs41 topic
- Drug Delivery41 topic
- Nanocarriers41 topic
- Prenatal Exposure41 topic
Where does Ricardo Nalda‐Molina work?
Ricardo Nalda‐Molina's main affiliation in the publication record is Universitat de Miguel Hernández d'Elx, Spain.
How many publications and citations does Ricardo Nalda‐Molina have?
OpenAlex counts 38 works and 598 citations for Ricardo Nalda‐Molina, an h-index of 13, ranking #5,589,262 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ricardo Nalda‐Molina. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.